Syngene
An integrated contract research, development, and manufacturing firm, Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) offers scientific services ranging from early discovery to commercial supply. We serve a wide range of industrial sectors, including those in the pharmaceutical, biotechnology, nutrition, animal health, consumer products, and specialty chemical industries, with our creative capabilities for novel molecular entities (NMEs). Early-stage research, from target identification to the delivery of therapeutic candidates for future development, is one of our discovery services. Development services cover pre-clinical and clinical trial activities such as Drug Substance Development (DSP), Drug Product Development (DPD), and related services to prove the safety, tolerability, and efficacy of the chosen drug candidate.
An integrated contract research, development, and manufacturing firm, Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) offers scientific services ranging from early discovery to commercial supply. We serve a wide range of industrial sectors, including those in the pharmaceutical, biotechnology, nutrition, animal health, consumer products, and specialty chemical industries, with our creative capabilities for novel molecular entities (NMEs). Early-stage research, from target identification to the delivery of therapeutic candidates for future development, is one of our discovery services. Development services cover pre-clinical and clinical trial activities such as Drug Substance Development (DSP), Drug Product Development (DPD), and related services to prove the safety, tolerability, and efficacy of the chosen drug candidate.
Syngene has raised $145M across 1 round. Its most recent round was a Series Unknown of $145M in Feb 2023. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Syngene is featured in
Similar companies
Primaa develops artificial intelligence-based software for automated and accurate histological and cancer diagnoses.
Supply6 is a food supplement brand that professes to give nourishing enhancements in drinkable structures like smoothies. Supply6 is a nourishment complete dinner made from genuine food fixings, to give you all the 6 full scale and micronutrients you want to get past the day and keep a sound, blissful life.
Rubicon Research is a leading Drug Delivery Technology company based in India and is known as a top outsourcing partner in the pharmaceutical industry worldwide.
Humeta is a sophisticated AI system designed specifically for healthcare, it has been trained on a vast amount of medical research and guidelines.
Welltopia is a kids-first health and wellness company that is revolutionizing the way families handle daily care by developing clean-label, scientifically supported solutions and wellness essentials that are joyful, safe, and trusted by parents.
Luma Fertility simplifies fertility care, removes stress, and tailors it to each individual.
Utopia Therapeutics is a biotech start-up that is transforming chronic care with innovative vaccines.
Janitri creates sustainable technology to enhance healthcare for mothers and children.
At SRV Hospital, a wide range of medical services are offered including plastic surgery, psychiatry, pediatrics, orthopedics, oncology, physiotherapy, neurology, gynecology, general surgery-laparoscopy, gastroenterology, ear, nose, and throat (ENT), dietetics, dermatology, pulmonary/respiratory medicine, nephrology, and cardiology.
That Sassy Thing is a brand focused on sexual wellness that aims to redefine intimacy in a laid-back and nonjudgmental way for individuals over the age of 21.
Stance Health is a healthtech startup that primarily specializes in providing care for musculoskeletal issues.
Tvaster Genkalp is a healthcare company that specializes in Liquid Biopsy to detect DNA abnormalities.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.